Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 49 to 50 of 50 entries
Sorted by: Best Match Show Resources per page
Epigenetic Inactivation of the Tumor Suppressor .

Cancers

Küster MM, Schneider MA, Richter AM, Richtmann S, Winter H, Kriegsmann M, Pullamsetti SS, Stiewe T, Savai R, Muley T, Dammann RH.
PMID: 33256112
Cancers (Basel). 2020 Nov 26;12(12). doi: 10.3390/cancers12123528.

No abstract available.

Cite
Küster MM, Schneider MA, Richter AM, et al. Epigenetic Inactivation of the Tumor Suppressor . Cancers (Basel). 2020;12(12)doi: 10.3390/cancers12123528.
Küster, M. M., Schneider, M. A., Richter, A. M., Richtmann, S., Winter, H., Kriegsmann, M., Pullamsetti, S. S., Stiewe, T., Savai, R., Muley, T., & Dammann, R. H. (2020). Epigenetic Inactivation of the Tumor Suppressor . Cancers, 12(12), . https://doi.org/10.3390/cancers12123528
Küster, Miriam M, et al. "Epigenetic Inactivation of the Tumor Suppressor ." Cancers vol. 12,12 (2020). doi: https://doi.org/10.3390/cancers12123528
Küster MM, Schneider MA, Richter AM, Richtmann S, Winter H, Kriegsmann M, Pullamsetti SS, Stiewe T, Savai R, Muley T, Dammann RH. Epigenetic Inactivation of the Tumor Suppressor . Cancers (Basel). 2020 Nov 26;12(12). doi: 10.3390/cancers12123528. PMID: 33256112; PMCID: PMC7760495.
Copy Download .nbib Format: NLM
Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion.

Cancer cell

Lan Y, Moustafa M, Knoll M, Xu C, Furkel J, Lazorchak A, Yeung TL, Hasheminasab SM, Jenkins MH, Meister S, Yu H, Schlegel J, Marelli B, Tang Z, Qin G, Klein C, Qi J, Zhou C, Locke G, Krunic D, Derner MG, Schwager C, Fontana RE, Kriegsmann K, Jiang F, Rein K, Kriegsmann M, Debus J, Lo KM, Abdollahi A.
PMID: 34506739
Cancer Cell. 2021 Oct 11;39(10):1388-1403.e10. doi: 10.1016/j.ccell.2021.08.008. Epub 2021 Sep 09.

Localized radiotherapy (RT) induces an immunogenic antitumor response that is in part counterbalanced by activation of immune evasive and tissue remodeling processes, e.g., via upregulation of programmed cell death-ligand 1 (PD-L1) and transforming growth factor β (TGF-β). We report...

Cite
Lan Y, Moustafa M, Knoll M, et al. Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion. Cancer Cell. 2021;39(10):1388-1403.e10doi: 10.1016/j.ccell.2021.08.008.
Lan, Y., Moustafa, M., Knoll, M., Xu, C., Furkel, J., Lazorchak, A., Yeung, T. L., Hasheminasab, S. M., Jenkins, M. H., Meister, S., Yu, H., Schlegel, J., Marelli, B., Tang, Z., Qin, G., Klein, C., Qi, J., Zhou, C., Locke, G., Krunic, D., Derner, M. G., Schwager, C., Fontana, R. E., Kriegsmann, K., Jiang, F., Rein, K., Kriegsmann, M., Debus, J., Lo, K. M., & Abdollahi, A. (2021). Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion. Cancer cell, 39(10), 1388-1403.e10. https://doi.org/10.1016/j.ccell.2021.08.008
Lan, Yan, et al. "Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion." Cancer cell vol. 39,10 (2021): 1388-1403.e10. doi: https://doi.org/10.1016/j.ccell.2021.08.008
Lan Y, Moustafa M, Knoll M, Xu C, Furkel J, Lazorchak A, Yeung TL, Hasheminasab SM, Jenkins MH, Meister S, Yu H, Schlegel J, Marelli B, Tang Z, Qin G, Klein C, Qi J, Zhou C, Locke G, Krunic D, Derner MG, Schwager C, Fontana RE, Kriegsmann K, Jiang F, Rein K, Kriegsmann M, Debus J, Lo KM, Abdollahi A. Simultaneous targeting of TGF-β/PD-L1 synergizes with radiotherapy by reprogramming the tumor microenvironment to overcome immune evasion. Cancer Cell. 2021 Oct 11;39(10):1388-1403.e10. doi: 10.1016/j.ccell.2021.08.008. Epub 2021 Sep 09. PMID: 34506739.
Copy Download .nbib Format: NLM
Showing 49 to 50 of 50 entries